FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Cannabix Technologies Improves Performance of FAIMS Marijuana Breathalyzer – CNN Coverage.”
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO) developer of marijuana breathalyzer devices for law enforcement and the workplace, reports that engineers have developed and deployed new ion optics methods that have resulted in a 6 times increase in analyte signal which has increased the sensitivity in the Company’s FAIMS (field asymmetric waveform ion mobility spectrometry) ∆9-tetrahydrocannabinol (“THC”) detection device. The Company has been working for the last several months on improving “ion optics” which is a critical component of the FAIMS system in order to better focus and maximize ion flow through the FAIMS cell “keyhole”. Members of Cannabix advisory team, including Dr. Yost and Dr. Purves were instrumental in providing guidance on the latest technological enhancements leading to this improvement. Furthermore, the Company reports that Cannabix scientists have been testing with a single stage, direct breath with the FAIMS device, that allows for real-time collection and analysis of low volatility compounds without sample preparation.
Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing durable, portable tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many global jurisdictions. Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples. In particular, Cannabix is focused on developing breath testing devices for detection of recent use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects usage, days or even weeks earlier. The devices will also be useful for other practical applications such as testing employees in the workplace where impairment by THC can be hazardous.
Early in December, Michigan started legally selling recreational cannabis, becoming the first state in the Midwest to legalize adult-use marijuana use. It is now the 10th state to legalize the sale of cannabis products for both recreational and medical use, further augmenting the perpetual spread of successful referendums supporting full legalization. However, despite widespread legalization efforts, many consumers still tend to purchase their products from illegal vendors. In particular, one year after Canada fully legalized cannabis, 60% of Canadians still obtain their products from black market dealers or sources that are not entirely legal. Nevertheless, the percentage has steadily fallen since Canada legalized cannabis back in October 2018. Currently, consumers purchase their products from the black market because it is typically much cheaper than obtaining goods from legal vendors. According to a study by Statistics Canada, legal cannabis now costs 65% more than black market products, increasing from 50% in the fourth quarter of 2018. And while legal cannabis may be expensive to most consumers, a study by Brightfield Group discovered that 43% of the respondents were willing to pay more for premium products, while just 34% were reluctant to pay more for certified organic goods. In the meantime, the cannabis industry is becoming more widely accessible to the public all around the world. And according to data compiled by ArcView Market Research and BDS Analytics, worldwide consumer spending on legal cannabis reached an estimated USD 12.2 Billion in 2018. By 2022, it is expected for consumer spending to reach USD 31.3 Billion while registering a CAGR of 26.7% from 2017 to 2022.
As sales of such products are becoming more prevalent, new and important regulations are expected to be implemented. Specifically, government regulators have voiced their concerns over the potential for cannabis abuse. Similar to abuse of alcohol, regulators are worried that consumers may commit some sort of activity that could endanger themselves or others while under the influence of the drug. It has been proven that large amounts of cannabis can have significant mind-altering effects, in turn, weakening the consumer and make driving, for example, more dangerous. As such, the need for a marijuana breathalyzer was understood. Government agents such as police officers can use the breathalyzer on someone who they may suspect is under the influence of marijuana. And according to a study published in the U.S. National Library of Medicine National Institutes of Health, driving while under the influence of cannabis is 1.65 times more likely to cause an accident. Furthermore, a recent article published by CNN explains that several tech startups and university scientists say they’re close to commercializing something resembling a cannabis breathalyzer, “We aren’t measuring impairment, we’re measuring THC in breath where it lasts a very short period of time, providing objective data about THC in breath to law enforcement and employers to use in conjunction with other information they have gathered,” said Hound Labs founder Mike Lynn, an emergency room doctor, reserve Deputy Sheriff and venture capitalist.
For more information, please visit: Cannabix Technologies Inc.
For more corporate news on Cannabix Technologies Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.